Biocon is engaged in the business of manufacture of biotechnology products and research services.
Financial Results:
Biocon Ltd reported Revenues for Q2FY24 of ₹3,462.00 Crores up from ₹2,320.00 Crore year on year, a rise of 49.22%.
Total Expenses for Q2FY24 of ₹3,382.00 Crores up from ₹2,138.00 Crores year on year, a rise of 58.19%.
Consolidated Net Profit of ₹173.00 Crores up 110.98% from ₹82.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.05, up 169.23% from ₹0.39 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.